4th Quarter - Report

FOLEY HOAG LLP for MEDIMMUNE INC

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Follow-on Biologics legislation - S 623, HR 1038, HR 1956, S 1695 Food and Drug legislation - S 1082, HR 2900 Safe-guarding America's Pharmaceutical Act - HR 5839

LobbyistCovered position, as disclosed
KELLY CHILDRESS Congressman Rogers Staff; Congressman Shimkus, Staff
PAUL KIM —
DAVID MOHLER —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1038 (110th), H.R. 1956 (110th), H.R. 5839 (110th), H.R. 2900 (110th)

Medicare/Medicaid MMM

Medicaid Rebate Issues FDA Globalization Act - HR 3610, S 3409 Medicare Improvement for Patients and Providers Act - HR 6331

LobbyistCovered position, as disclosed
PAUL KIM —
DAVID MOHLER —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6331 (110th), H.R. 3610 (110th)

Copyright/Patent/Trademark CPT

Patent Reform Act of 2007; S 1145, HR 1908

LobbyistCovered position, as disclosed
PAUL KIM —
DAVID MOHLER —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1908 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.